ELV

NYSEElevance Health Inc
Calm Tide · 47Squeeze · Idle 21Neutral0 buys · $0Social · Quiet 0
$401.94
$-5.56 (-1.36%)
15-min delayed · Sep 8, 7:19 PMReal-time

Score summary

Buy
Analyst Ratings
20Ratings
14 Buy6 Hold0 Sell
Tide Score
47
Calm Tide · stable · Bottom 42% of universe (3990)
Outlook55High Tide · stable · Top 43% of universe (3991)
Squeeze Score
21
Idle ·
  • Days to cover5.67
  • Short interest2.66% of float
  • Borrow rate30.51%
  • Short interest trend-0.08% (30d)
Trend
Neutral
No clear trend (signals split)
Recent Smart Money
0 buys
Quiet · $0 · 14d · 5 super investors

Key statistics

Market Cap
$88.37B
52-week range
$279.02 – $426.79
46% from low
Day range
$406 – $414
Open $411.12
Volume
1.1M
vs 959k avg · 118%
P/E (TTM)
18.4
Fwd 14.0
Earnings
Oct 21
43d · est $4.66

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 20 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$456
20 Wall St 12-month targets
High
$498
Average
$438
Low
$343
$272$331$389$448$507HIGH$498MEDIAN$456LOW$343Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 68/100 Analyst Score (Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Oct 21 (post-market, est EPS $4.66) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.